Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcella Willemsen

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancers|November 11, 2022
Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic CancerFreek R van 't Land, Sai P Lau, Willem de Koning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2024
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic CancerFreek R van 't Land, Marcella Willemsen, Koen Bezemer, et al.
Frontiers in Immunology|November 29, 2023
B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patientsEveline E Vietsch, Diba Latifi, Maaike Verheij, et al.
Nature Communications|November 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancerSongul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancers|November 11, 2022
Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic CancerFreek R van 't Land, Sai P Lau, Willem de Koning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2024
Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic CancerFreek R van 't Land, Marcella Willemsen, Koen Bezemer, et al.
Frontiers in Immunology|November 29, 2023
B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patientsEveline E Vietsch, Diba Latifi, Maaike Verheij, et al.
Nature Communications|November 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancerSongul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg, et al.
Pageof 3